Experimental Type 2 Diabetes Differently Impacts on the Select Functions of Bone Marrow-Derived Multipotent Stromal Cells
Bone marrow-derived multipotent stromal cells (BMMSCs) represent an attractive therapeutic modality for cell therapy in type 2 diabetes mellitus (T2DM)-associated complications. T2DM changes the bone marrow environment; however, its effects on BMMSC properties remain unclear. The present study aimed...
Main Authors: | Jonathan Ribot, Cyprien Denoeud, Guilhem Frescaline, Rebecca Landon, Hervé Petite, Graciela Pavon-Djavid, Morad Bensidhoum, Fani Anagnostou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/2/268 |
Similar Items
-
Type 2 diabetes impairs mesenchymal stem cells functions and differentiation
by: Jonathan Ribot, et al.
Published: (2020-10-01) -
Transcriptome Analysis of Dnmt3l Knock-Out Mice Derived Multipotent Mesenchymal Stem/Stromal Cells During Osteogenic Differentiation
by: Chih-Yi Yang, et al.
Published: (2021-02-01) -
Neuroblastoma-secreted exosomes carrying miR‐375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells
by: Marta Colletti, et al.
Published: (2020-01-01) -
Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01) -
Potential Marker Genes for Predicting Adipogenic Differentiation of Mesenchymal Stromal Cells
by: Masami Kanawa, et al.
Published: (2019-07-01)